Food and Drug Regulatory Trends and Developments: Navigating Implications for the Year Ahead

Broadcast Date: Wednesday, August 05, 2020 from 3:00 pm to 4:00 pm (ET)
Jennifer Mallory
Beth P. Weinman


About Nelson Mullins Riley & Scarborough LLP

Nelson Mullins is an AmLaw 100 firm serving clients in more than 100 diversified practice areas. From a firm of one attorney in 1897 to 800+ attorneys, policy advisors, and professionals in 11 states and the District of Columbia today, we represent corporate and individual clients in a wide variety of areas, including: food/drug/device law, regulatory, healthcare, litigation, intellectual property, real estate capital markets, corporate, technology, banking, e-discovery, economic development, securities, finance, tax, estate planning, governmental relations, environmental, real estate, labor and employment, privacy and security, and white collar crime. Nelson Mullins’ clients range from Fortune 500 companies to private equity and venture funds and portfolio companies to emerging growth companies and start-ups.


About Ropes & Gray LLP

Ropes & Gray is a leading global law firm with 11 offices located around the world. Our Washington, D.C.-based FDA regulatory team includes seasoned lawyers knowledgeable in all areas of FDA regulation. The team’s varied backgrounds bring a breadth of perspectives to the practice which includes attorneys who have worked at the FDA, as in-house counsel at life sciences companies and as key policy advisors in Congress.

As part of our multidisciplinary life sciences group, our FDA regulatory team has a broad view of the commercial and regulatory forces affecting life sciences companies. In addition to traditional regulatory counseling and administrative litigation, we advise clients on corporate and transactional matters, government enforcement investigations, compliance program design and implementation, and FDA-related intellectual property analyses and litigation.